In today’s recent session, 0.45 million shares of the Organovo Holdings Inc (NASDAQ:ONVO) have been traded, and its beta is 0.48. Most recently the company’s share price was $0.35, and it changed around $0.01 or 1.52% from the last close, which brings the market valuation of the company to $5.32M. ONVO at last check was trading at a discount to its 52-week high of $1.74, offering almost -397.14% off that amount. The share price’s 52-week low was $0.32, which indicates that the recent value has risen by an impressive 8.57% since then. We note from Organovo Holdings Inc’s average daily trading volume that its 10-day average is 0.15 million shares, with the 3-month average coming to 77.10K.
Organovo Holdings Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended ONVO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Organovo Holdings Inc is expected to report earnings per share of -0.2 for the current quarter.
Organovo Holdings Inc (NASDAQ:ONVO) trade information
Instantly ONVO has been showing a green trend so far today with a performance of 1.52% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4350 on recent trading dayincreased the stock’s daily price by 19.54%. The company’s shares are currently down -68.79% year-to-date, but still down -3.78% over the last five days. On the other hand, Organovo Holdings Inc (NASDAQ:ONVO) is -24.86% down in the 30-day period. We can see from the shorts that 0.15 million shares have been sold at a short interest cover period of 1.97 day(s).
Organovo Holdings Inc (ONVO) estimates and forecasts
Organovo Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -66.69 percent over the past six months and at a 51.88% annual growth rate that is well above the industry average of 18.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 50.00% in revenue this quarter, and will report an increase of 74.63% in the next quarter. The year-over-year growth rate is expected to be -45.68%, down from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 50k in revenue for the current quarter. 1 analysts expect Organovo Holdings Inc to make 54k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 5k and 290k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 900.00%. Forecasts for the next quarter put sales growth at -81.38%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 19.06%.
ONVO Dividends
Organovo Holdings Inc’s next quarterly earnings report is expected to be released in December.
Organovo Holdings Inc (NASDAQ:ONVO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.03% of Organovo Holdings Inc shares, and 15.88% of them are in the hands of institutional investors. The stock currently has a share float of 16.21%. Organovo Holdings Inc stock is held by 33.0 institutions, with ARMISTICE CAPITAL, LLC being the largest institutional investor. By 2024-06-30, it held 9.2183% of the shares, which is about 0.93 million shares worth $0.71 million.
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., with 4.7035% or 0.47 million shares worth $0.36 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 238.97 shares worth $85050.0, making up 1.56% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 114.64 shares worth around $40800.0, which represents about 0.75% of the total shares outstanding.
